课题基金 / 基金详情

Procaspase 8 Activation by HIV Protease

Procaspase 8 Activation by HIV Protease
HIV 蛋白酶激活半胱氨酸蛋白酶原 8
批准号:
7057775
负责人:
ANDREW D BADLEY
金额:
$32.41万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2004
资助国家:
美国
项目状态:
已结题
起止时间:
2004-05-01 至 2009-04-30

项目摘要

项目成果

ANDREW D BADLEY的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): It remains controversial as to how CD4+ T cells directly infected with HIV die following infection. Numerous mechanisms have been proposed to account for infected cell killing, however none of the proposed mechanisms are universally accepted. It has long been recognized that one HIV protein, HIV protease, is intrinsically cytotoxic as its expression causes the death of bacteria, yeast, and mammalian cells, however it remains unclear how HIV protease kills these cells. Experimental data now demonstrate that HIV protease cleaves host cell proteins in addition to viral proteins. Our laboratory has recently defined one mechanism by which HIV protease can kill cells; specifically HIV protease can cleave the apoptosis initiating protein, procaspase 8, to result in its activation. Thereafter, a traditional apoptosis cascade is initiated, ultimately resulting in the structural, nuclear, and morphologic changes associated with apoptosis. While we have demonstrated that this mechanism of HIV protease mediated killing can occur, we have yet to determine whether or not this mechanism does occur, particularly in vivo. The focus of the current proposal is to define the relevance of this form of cell killing both in infections, which occur in the test tube, as well as in patients. The clinical significance of this research may be reflected in recent clinical observations, suggesting an altered diseased course of patients who have infections with HIV that contain mutations within the HIV protease gene as compared to those that do not. We will explore the potential impact of these mutations by assessing the differential impact of wild type HIV protease versus mutant protease on procaspase 8 activation and cell killing.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Evaluating the role of the novel apoptosis inhibitor TRAILshort, in maintaining HIV persistence.
  • 批准号:
    8990167
  • 项目类别:
  • 资助金额:
    $50.57万
  • 财政年份:
    2015
  • 负责人:
    ANDREW D BADLEY
  • 依托单位:
Evaluating the role of the novel apoptosis inhibitor TRAILshort, in maintaining HIV persistence.
  • 批准号:
    9272805
  • 项目类别:
  • 资助金额:
    $50.57万
  • 财政年份:
    2015
  • 负责人:
    ANDREW D BADLEY
  • 依托单位:
Evaluating the role of the novel apoptosis inhibitor TRAILshort, in maintaining HIV persistence.
  • 批准号:
    9089882
  • 项目类别:
  • 资助金额:
    $50.57万
  • 财政年份:
    2015
  • 负责人:
    ANDREW D BADLEY
  • 依托单位:
Evaluating the role of the novel apoptosis inhibitor TRAILshort, in maintaining HIV persistence
  • 批准号:
    10427482
  • 项目类别:
  • 资助金额:
    $60.69万
  • 财政年份:
    2015
  • 负责人:
    ANDREW D BADLEY
  • 依托单位:
海外基金